Transaction · 0001193125-26-444851

Collard Craig A

Collard Craig A, CEO, reported a transaction classified as exercise at HERON THERAPEUTICS, INC. DE involving 34788.000000 shares for an estimated $0.00. Reported holdings after the transaction were 313098.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

exerciseSEC transaction code MCEO
HRTXHERON THERAPEUTICS, INC. DE
Disclosed value$0Shares × reported price
Shares traded34.7k$0.00 per share
Holdings after313kDirect
% of reported position tradedUnavailableThis security and ownership context
How reported position traded is calculated

Not calculated for derivative securities.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

HRTX price since this filing

Daily closing prices, with the filing date and available return windows
HRTX · Daily closing priceLoading daily prices…
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago +24.1%1w ago +3.4%1d ago -6.9%
Returns since7d30d90d180d1y

Transaction facts

Stored Form 4 columns with their raw values

Derivative
Type
exercise
Code M
Identifier
0001193125-26-444851
Restricted Stock Units
Transaction date
Oct 31, 2026
Filed Nov 03, 2026, 05:57 PM · 3d delay
Shares
34,788 sh
$0.00 per share
Estimated value
$0
Computed from shares × price
Holdings after
313,098 sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Derivative Transaction Direct Ownership
Filing-only score

-10 points

Compact filing score computed from stored Form 4 facts. Version v1.

Mixed or weak signal

This filing has a negative filing-only score. It may be less informative as an insider-activity signal and needs extra context.

How this score is calculated
  • direct_ownership+6 points

    direct_or_indirect_ownership = D

    Direct ownership reports the insider's personal stake.
  • derivative_transaction-16 points

    is_derivative = true

    Derivative exercise rows are less discretionary than open-market purchases.
Read the scoring methodology

Signed filing-only points, not a probability or expected return. Version v1.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

Chief Executive Officer

Officer YesDirector Yes10% NoOther No
Footnotes & amended
  1. F1

    Each restricted stock unit represents a contingent right to receive one share of common stock.

  2. F2

    On January 30, 2026 (the "Date of Grant"), the Reporting Person was granted 800,337 RSUs which vest upon the following time-based vesting schedule: the RSUs vest in 16 equal quarterly installments beg…

  3. F3

    The restricted stock units vest in 16 equal installments beginning one quarter after the date of grant (January 31, 2025).

Original filing · 0001193125-26-444851
Related transactions

0 other transactions

Same SEC filing
Recent company activity

0 recent txs

HRTX